Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,028,002
+$413,327 QoQ
Shares Held
8,416
-1.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#261
of 640 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fiduciary Trust Co holds $29,735,828 across 28 Biotechnology names. JAZZ ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,400 | $9,636,561 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,318 | $5,186,605 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
17,991 | $3,369,353 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
8,416 | $2,028,002 | |
| 5 | VYGR |
Voyager Therapeutics, Inc.
|
334,397 | $1,170,389 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
2,471 | $781,057 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
8,537 | $635,835 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
7,399 | $586,666 |
All Filings in JAZZ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,028,002 | 8,416 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,614,675 | 8,541 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,908,930 | 11,229 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,636,164 | 12,414 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,433,786 | 13,511 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,393,696 | 43,445 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $786,435 | 6,386 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $754,244 | 6,770 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $482,846 | 4,524 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $366,437 | 3,043 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||